“Commonly known as the stomach flu, norovirus has been around forever, and has become the leading cause of gastroenteritis or ...
Moderna's bird flu vaccine development, supported by a U.S. government grant, could be a game changer if the bird flu spreads ...
The biotech’s efforts to bring its vaccines to the country mean navigating political pushback in the U.S. and the risk of ...
Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.
Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.
The biotech group struggled as a whole in 2024, but analysts say the innovation that has always supported the biotech ...
Five years on from the first news of COVID, recent reports of an obscure respiratory virus in China may understandably raise ...
Shares of Moderna Inc. fell over 8% on Wednesday afternoon, paring some of the gains from Tuesday, the stock’s best trading ...
In absolute dollar amount, the Cambridge drugmaker had the biggest drop in market cap among any public Massachusetts company ...
Moderna stock has been volatile this week as the first death in the U.S. connected to bird flu was reported. Here's what you ...